No accumulation of SNAC plasma exposure was observed during the 10 weeks of once-daily dosing (data not shown)
A large real-world study published in 2026 in the journal Inflammatory Bowel Diseases found that GLP-1 use in people with UC and Crohns disease was linked to lower rates of steroid use, hospitalization, and intestinal surgery
Potential Side Effects of Oral GLP-1 and Injectable Semaglutide Nausea or "queasiness" Changes in bowel habits (constipation or diarrhea) Heartburn Since the pill is a daily dose, some patients find the side effects are more consistent throughout the week, whereas the injection can sometimes cause a "peak" of symptoms a day or two after the shot, then improve
It is often used when diet and exercise alone are insufficient to manage blood sugar levels
Current Applications Differentiation into Insulin-Producing Cells Further applications for GLP1-RA, primarily Ex-4, on hMSC include the differentiation into insulin-producing cells (IPC), a process of significant interest for regenerative approaches in gastroenterology
Vector and insert fragments were linearized by polymerase chain reaction (PCR) and template DNA was digested with DpnI